The Geographical Disease Risk Index forms a constituent part of Chapter 3, Chapter 20 and Chapter 22 of the Guidelines for the Blood Transfusion and Tissue Transplantation Services in the UK.
JPAC is responsible for this document and receives professional advice from the Standing Advisory Committees that form part of its structure and from other relevant expert groups. The criteria are reviewed regularly to ensure that the products collected are of the highest quality and of sufficient quantity to meet the needs of recipients. The guidelines on this website are always up-to-date, but implementation dates may vary between the four UK Services. Please consult your local Service (England, Scotland, Wales or Northern Ireland) for details of implementation dates.
Please note, these guidelines are for use by medical professionals who are trained in their use. It is not possible to answer questions or provide personal medical advice through this website. Help with such matters may be available through a local blood transfusion and tissue transplantationhelpline.
To navigate the guidelines online use the A-Z Search. To download a portable document file (PDF) as resource for a printed version, or to download an off-line browser version, see the Source Files. Users of these guidelines must ensure that they have the latest version and that recent changes have been implemented by their Service.
Updates lists alterations to the guidelines made since publication of this edition.
Comments about the content of these guidelines, including notification of errors, omissions and suggestions for improvements, should be sent to the interim Chair of the Standing Advisory Committee on Care and Selection of Donors (SACCSD):
The GDRI should be used to assist selection of donors giving whole blood, blood components (red cells, platelets, plasma and granulocytes), haemopoietic progenitor cells and tissues for therapeutic use.
Donor Selection Procedures aim to minimize the risk of transfusion transmitted infection. Travel to; birth/maternal birth or residency in; and in some cases sexual activity with residents of certain countries, is associated with an increased risk of exposure to infections such as malaria, T cruzi, WNV and HIV. These risks may vary over time and new diseases may occur. Where there is a rapidly emerging geographical disease risk (e.g. SARS or Pandemic Flu) these will be communicated via a Change Notification to be used in conjunction with this document.
This list is compiled specifically for risks to the blood and tissue supply in the United Kingdom and may vary from risks or recommendations provided for the protection of the traveller.
To assess the risk of an individual carrying such infections, look up the countries:
that they have visited
for which they report sexual contact with a resident or former resident
in which they were born
in which their mother was born
If a risk is shown for that country, look at the relevant entry in the appropriate Donor Selection Guidelines (DSG) for the donation type (e.g. Whole Blood & Components or the relevant Tissue DSG) to assess the individual’s suitability to donate.
Information concerning malaria risk has been sourced from Health Protection Scotland (www.travax.nhs.uk/) with some modifications to account for typical donor travel patterns, entry points to the countries concerned, areas where reporting is compromised and ease of use for end users. They are not identical to those found on the ‘Fit for Travel’ website which is designed to inform travellers decisions about anti-malarial therapy rather than give assurance of safety of blood donations for recipient patients.
Countries with malarial risk have been categorised into three groups:
Category A
Countries where the malarial risk is present in the whole country all year or with very clear seasonal guidance
Category B
Countries where only parts of the country are affected
Category C
Indicates that only part of the country is affected in discrete pockets, or the risk of infection is low or that there are few visitors to the affected areas.
It is likely that tourists who visit these countries will be able to donate but individual assessment must be applied. Donors are likely to have detailed knowledge of the malarial areas visited.
The health care professional should establish whether the donor sought advice prior to travel or not and if they were advised to take anti malarial precautions.
Malaria Maps
The maps included are to be used to accompany the GDRI when assessing the malaria risk for a donor. They have been sourced from the Fit for travel website. It is important to apply the GDRI guidance for all infection risks; these maps only provide advice for malaria risk.
Use Of Maps
Maps are provided to allow staff to assess the malaria risk for the areas within these countries that a donor has visited. The text of the GDRI should be taken as the main source to make decisions. The maps present information about neighbouring countries but this should not be used for malarial assessment. The advice below each map relates to the Fit for travel website. Decisions regarding malaria guidance should be made using the template below.
The definition of an Airport Stopover, as approved by The Standing Advisory Committee on Transfusion Transmitted Infections, is a transit through an airport during which the traveller has not left the airport.
When the donor's visit has consisted only of an airport stopover there is no need to refer to the Geographical Disease Risk Index.
HIV/AIDs
HIV/AIDS is common in some areas of the world, and sexual activity with partners in these countries carries a risk of infection. This Index identifies the countries of Sub Saharan Africa to facilitate interpretation of the guidance. However the health care professional should consider all other risks of HIV associated with travel and remember that this is not restricted to Sub Saharan Africa.
If the donor reports sexual activity with a partner in one of the countries listed as Sub Saharan Africa in the table, or with a partner who may have been sexually active in one of these areas, refer to the Blood Safety Entry in the Donor Selection Guidelines.
Document and change control
The GDRI is under the continuing review of the Standing Advisory Committees for the Care and Selection of Donors (SACCSD) and for Transfusion Transmitted Infection (SACTTI). This is to ensure that they are accurate and up to date. All changes have the approval of the UKBTS Joint Professional Advisory Committee (JPAC).
Change Notification
Changes are notified to the Medical Director and to the Quality Manager of each of the four national services by a Change Notification from the Chairman of JPAC. All changes will have the approval of JPAC.
Implementation of changes is the responsibility of the individual national service.
Version terminology
A version shall be any of the following:
Extensive revisions of this document are known as 'Editions'.
Changes following the issue of 'Change Notification Letters' are known as 'Releases'.
Changes to the website, which do not involve a change to the medical or scientific content, are given an 'Issue' number.
Edition Date, Release Date and Issue Date is the date on which an Edition, Release or Issue is first published on the UKBTS website.
Changes to printed versions
The Quality Manager of each Blood Service will effect changes to the document. They will be informed when a new electronic version is released.
The Quality Manager is responsible for ensuring that there is an effective Document Control and Document Change procedure in operation within their Blood Service to ensure that only up to date versions are in use and that all authorized copies, both electronic and paper, are traceable.
Individual users of the GDRI are responsible for ensuring that they are using an up-to-date version.
Changes to the website versions
The website will always display the up to date version. Any errors should be notified to JPACOffice@nhsbt.nhs.uk
This page was last updated in GDRI Edition 002 Release 24.